meet
american
associ
cancer
research
atlant
citi
charlott
friend
report
isol
viru
produc
fatal
leukemia
inocul
adult
mice
time
concept
virus
caus
cancer
still
view
extrem
skeptic
present
data
young
woman
long
graduat
school
met
disbelief
deris
diamond
dr
friend
prove
correct
friend
viru
fv
becam
primari
tool
studi
viral
leukemogenesi
oncolog
host
resist
infect
origin
report
dr
friend
test
seven
differ
strain
mice
found
two
strain
suscept
leukemia
find
elicit
great
deal
interest
determin
genet
host
suscept
resist
mendelian
studi
complic
fact
genet
cross
suscept
resist
control
multigen
factor
fieldsteel
dawson
bostick
franker
quilligan
mirand
mirand
grace
buffett
lilli
mid
frank
lilli
map
first
fv
suscept
trait
chromosom
link
major
histocompat
complex
mhc
mous
lilli
boys
old
lilli
second
viral
suscept
trait
ever
map
time
mhc
known
control
graft
accept
reject
mous
strain
mechan
action
understood
link
viru
suscept
resist
intrigu
landmark
paper
zinkernagel
doherti
elucid
connect
mhc
cell
respons
viral
infect
studi
suggest
discrimin
self
nonself
tissu
graft
extend
cell
recognit
alter
self
viral
infect
cell
zinkernagel
doherti
b
phenomenon
understood
viral
peptid
nonself
bound
mhc
molecul
self
collabor
jack
stimpfl
bruce
chesebro
use
mhc
recombin
mice
map
fv
resist
trait
specif
gene
within
mhc
within
next
year
immunolog
mechan
genet
resist
uncov
includ
role
cell
respons
friedman
lilli
nathenson
blank
freedman
lilli
chesebro
wehrli
b
chesebro
wehrli
chesebro
wehrli
plata
lilli
b
cell
respons
chesebro
wehrli
chesebro
et
al
chesebro
et
al
immunolog
studi
move
era
molecular
immunolog
sever
key
find
allow
develop
tool
enabl
studi
fv
resist
much
detail
mechanist
level
discoveri
mhc
molecul
present
peptid
cell
review
van
bleek
nathenson
blum
wearsch
cresswel
roch
furuta
led
identif
fv
dbgagl
peptid
present
class
molecul
chen
et
al
fv
peptid
present
class
ii
molecul
iwashiro
et
al
shimizu
et
al
peptid
identif
enabl
develop
tetram
quantifi
fvspecif
cell
scheper
et
al
well
develop
tcr
transgen
mice
carri
cell
specif
dbgagl
ohlen
et
al
tcr
transgen
mice
specif
fv
antun
et
al
use
immunolog
tool
greatli
advanc
discoveri
immunolog
mechan
resist
fv
infect
relev
human
immun
sever
chronic
viral
infect
addit
adapt
immun
respons
requir
resist
fv
innat
intrins
immun
respons
also
play
import
role
review
well
although
fv
often
refer
retroviru
actual
complex
two
virus
replic
compet
friend
murin
leukemia
viru
fmulv
sometim
refer
helper
viru
replic
defect
viru
call
spleen
focusform
viru
sffv
kabat
fmulv
classifi
simpl
gammaretroviru
standard
arrang
ltr
flank
gag
pol
env
gene
troxler
ruscetti
scolnick
altern
cug
start
site
prat
et
al
use
produc
addit
protein
glycosyl
gag
glycogag
express
viral
particl
surfac
infect
cell
evan
dresler
kabat
fujisawa
et
al
nitta
et
al
interestingli
defect
sffv
predomin
pathogen
compon
fv
infect
adult
mice
sffv
encod
defect
env
protein
oncogen
properti
li
et
al
li
baltimor
gag
pol
gene
sffv
also
defect
sffv
must
coinfect
cell
infect
replic
compet
fmulv
helper
order
sffv
genom
get
packag
form
transduc
virion
cellular
tropism
fv
broad
fv
infect
divid
cell
except
hepatocyt
express
receptor
viral
entri
closs
et
al
said
prefer
target
fv
nucleat
erythroid
precursor
spread
virion
greatli
enhanc
bind
sffv
erythropoietin
receptor
short
form
stem
cell
kinas
receptor
sfstk
previous
known
li
et
al
person
et
al
et
al
interact
deliv
potent
prolif
signal
nucleat
erythroid
progenitor
significantli
magnifi
erythroid
target
popul
divid
cell
result
gross
splenomegali
hepatomegali
bone
marrow
hypertrophi
fact
mice
long
form
stk
lfstk
interact
highli
resist
fvinduc
splenomegali
diseas
tabl
fv
also
infect
b
cell
myeloid
cell
wherea
infect
level
cell
much
lower
windmann
et
al
resist
mice
infect
erythroid
precursor
effici
elimin
cell
infect
immun
cell
popul
partli
escap
cell
kill
infect
b
cell
subsequ
accumul
b
cell
follicl
windmann
et
al
specif
immunolog
nich
cytotox
cell
usual
ca
nt
excess
also
harbor
viral
reservoir
hiv
infect
human
siv
infect
monkey
connick
et
al
fukazawa
et
al
suscept
mice
fail
mount
rapid
helper
cell
cell
b
cell
respons
sffv
genom
eventu
integr
activ
transcript
factor
gene
moreaugachelin
tavitian
tambourin
paul
et
al
lavigueur
bernstein
paul
et
al
schuetz
et
al
hegd
hankey
paulson
inactiv
tumor
suppressor
gene
munro
peacock
benchimol
johnson
benchimol
johnson
chung
benchimol
produc
malign
erythroleukemia
multistag
manner
cmarik
ruscetti
although
erythroleukemia
human
rare
insight
fvinduc
erthroleukemia
also
reveal
much
develop
acut
myeloid
leukemia
human
similar
manner
fvinduc
erythroleukemia
least
two
oncogen
event
requir
one
bestow
prolif
advantag
one
disrupt
normal
differenti
recent
review
boddu
et
al
moreaugachelin
addit
stk
gene
describ
number
nonimmunolog
host
gene
involv
resist
suscept
fvinduc
leukemia
describ
review
chesebro
miyazawa
britt
hoatlin
kabat
moreaugachelin
boddu
et
al
review
focus
natur
immun
respons
result
suscept
resist
fv
infect
fv
power
tool
studi
immunolog
resist
retrovir
infect
infect
adult
immunocompet
mice
differ
mous
strain
vari
resist
fv
infect
tabl
studi
strain
use
defin
determin
genet
resist
also
immunolog
mechan
resist
wherea
highli
suscept
strain
mice
balbc
never
recov
acut
fv
infect
develop
rapid
erythroleukemia
resist
mice
recov
acut
infect
within
week
go
develop
lifelong
chronic
infect
thu
resist
mice
power
tool
studi
mechan
resist
acut
infect
also
mechan
retrovirus
evad
complet
erad
establish
maintain
chronic
mechan
immunolog
resist
acut
infect
rang
intrinis
immun
innat
adapt
immun
discuss
studi
chronic
fv
resist
mous
strain
yield
first
insight
respons
regulatori
cell
treg
suppress
critic
cell
respons
infect
therebi
promot
establish
chronic
fv
review
hasenkrug
chougnet
dittmer
review
also
discuss
involv
coinhibitori
molecul
suppress
immun
cell
popul
promot
chronic
fv
infect
addit
complex
natur
fv
addit
complic
discov
robertson
et
al
sinc
vivo
passag
fv
complex
alway
virul
cultur
viru
stock
clone
virus
studi
requir
highli
pathogen
viru
histor
done
use
mousepassag
swarm
stock
unintend
consequ
use
vivo
passag
stock
propag
endem
mous
viru
lactat
dehydrogenaseelev
viru
ldv
evid
indic
ldv
present
fv
stock
earli
riley
may
compon
fv
complex
first
isol
ldv
positivestrand
envelop
rna
viru
classifi
order
nidoviral
also
contain
coronavirus
drosten
et
al
ksiazek
et
al
peiri
et
al
name
deriv
capac
rapidli
infect
cytolys
subset
macrophag
clear
excess
lactat
dehydrogenas
circul
inada
mim
ldv
induc
rather
dramat
effect
immun
system
among
report
effect
impair
antigen
present
macrophag
isakov
feldman
segal
polyclon
b
cell
activ
couteli
van
snick
nk
cell
activ
markinegoriaynoff
et
al
impair
delayedtyp
hypersensit
respons
inada
mim
inhibit
cellular
immun
respons
howard
et
al
immunosuppress
effect
ldv
allow
fv
titer
reach
much
higher
level
infect
come
immunolog
control
robertson
et
al
duley
et
al
consequ
much
lower
dose
fv
requir
establish
chronic
fv
infect
presenc
ldv
absenc
furthermor
ldvinduc
polyclon
activ
b
cell
expand
popul
divid
target
cell
viru
entri
impact
ldv
explain
vivo
passag
fv
stock
virul
vitro
clone
stock
thu
studi
must
specifi
whether
viru
stock
contain
ldv
promin
exampl
effect
ldv
promot
virusneutr
antibodi
turn
highli
depend
presenc
ldv
stock
ldv
potent
induc
type
interferon
ifn
via
signal
ammann
et
al
mediat
antibodi
effect
depend
type
ifn
signal
observ
presenc
ldv
barrett
et
al
host
immun
system
abl
sens
invad
pathogen
varieti
germlineencod
receptor
pattern
recognit
receptor
prr
recogn
pathogenassoci
molecular
pattern
highli
conserv
molecular
structur
pathogen
wellcharacter
famili
prr
tolllik
receptor
tlr
locat
cellular
endosom
membran
endosom
sens
viral
nucleic
acid
compon
like
doublestrand
rna
singlestrand
rna
nonmethyl
cpgcontain
dna
respect
review
akira
takeda
beutler
cytosol
dna
rna
sensor
cyclic
gmpamp
synthas
cga
retino
acid
induc
gene
rigi
melanoma
differentiationassoci
protein
also
detect
replic
intermedi
mani
virus
gao
et
al
sun
et
al
viru
sens
induc
product
ifn
turn
lead
express
hundr
interferonstimul
gene
isg
elicit
antivir
state
infect
well
surround
cell
mani
vitro
studi
reveal
multipl
prr
cga
abl
sens
murin
retrovirus
possibl
retrovir
replic
cycl
singlestrand
doublestrand
hairpin
rna
loop
viral
rna
well
viral
dna
even
rnadna
hybrid
exist
acut
fv
infect
import
sensor
involv
control
viral
replic
gibbert
et
al
day
post
fv
infect
mice
defici
significantli
higher
viral
load
compar
wildtyp
mice
gibbert
et
al
acut
fv
infect
signal
critic
activ
myeloid
dendrit
cell
dc
subsequ
result
increas
cytotox
cell
natur
killer
nk
cell
mediat
reduct
viral
load
contrast
myeloid
differenti
primari
respons
import
adaptor
molecul
signal
pathway
tlr
famili
member
except
requir
viral
control
initi
fv
infect
howev
week
fv
infect
mice
fail
control
viru
due
impair
humor
immun
respons
brown
littman
kane
et
al
gibbert
et
al
sens
murin
leukemia
virus
mlv
crucial
develop
neutral
antibodi
respons
cell
respons
partial
depend
pathway
brown
littman
kane
et
al
mainli
express
myeloid
dc
indic
antigen
present
cell
primarili
activ
wherea
highli
express
differ
b
cell
subset
thu
humor
immun
respons
depend
signal
inde
anoth
studi
show
import
sensor
fv
infect
facilit
induct
germin
center
b
cell
brown
also
helper
cell
respons
diminish
fvinfect
mice
wherea
cell
respons
independ
brown
subsequ
studi
author
suggest
sens
might
also
critic
earli
fv
infect
sens
influenc
igm
antibodi
product
differ
viral
load
wildtyp
mice
rather
small
brown
recent
work
impli
retrovir
revers
transcript
also
detect
cellular
dna
sensor
cyclic
gmpamp
synthas
cga
dexdhbox
helicas
interferoninduc
protein
cga
interact
signal
sting
result
transcript
sever
gene
includ
type
ifn
alreadi
shown
cga
requir
cytosol
dna
exonucleas
three
prime
repair
exonucleas
trex
express
type
ifn
mlv
infect
gao
et
al
stavrou
et
al
cga
sens
doublestrand
viral
dna
seem
sens
viral
rnadna
hybrid
gener
first
step
murin
leukemia
viru
revers
transcript
sensor
requir
potent
antivir
innat
immun
stavrou
et
al
rna
sensor
zincfing
antivir
protein
induc
degrad
mlv
transcript
exosom
lee
et
al
wherea
cytosol
rna
sensor
like
rigi
affect
replic
mlv
fv
gibbert
et
al
lee
et
al
conclus
mani
dna
rnasensor
abl
recogn
replic
intermedi
murin
retrovirus
fig
prr
individu
role
host
innat
adapt
immun
respons
defin
howev
like
addit
pathway
exist
effici
sens
murin
retrovirus
initi
protect
immun
respons
mani
sensor
complet
independ
countermeasur
viru
may
compens
prr
target
differ
prr
retrovir
infect
might
improv
host
immun
respons
control
viral
replic
offer
novel
approach
antiretrovir
immunotherapi
olbrich
et
al
gibbert
et
al
mani
viral
infect
initi
host
respons
induct
ifn
type
ifn
famili
consist
numer
subtyp
bind
ifnar
compos
two
subunit
type
ifn
respons
initi
induc
sens
viral
nucleic
acid
variou
pattern
recognit
receptor
lead
express
earli
ifn
subtyp
erlandsson
et
al
mari
durbin
levi
bind
ifn
receptor
result
activ
janu
kinas
jak
signal
transduc
activ
transcript
stat
signal
pathway
induc
transcript
sever
hundr
gene
call
ifnstimul
gene
isg
gene
product
variou
biolog
function
directli
suppress
viral
replic
viral
protein
translat
viral
infect
clemen
elia
stark
et
al
isg
shown
directli
restrict
retroviru
replic
apobec
tetherin
tripartit
motif
trim
review
malim
bieniasz
ifn
also
inhibit
cell
tumor
prolifer
regul
innat
adapt
immun
respons
improv
host
immun
respons
activ
natur
killer
nk
cell
trinchieri
et
al
salazarmath
ishikawa
biron
stimul
antigen
present
machineri
epperson
et
al
hermann
et
al
includ
matur
dc
le
bon
et
al
augment
cell
honda
et
al
le
bon
et
al
b
b
cell
differenti
le
bon
et
al
le
bon
et
al
contrast
also
counteract
overwhelm
immun
respons
induct
antiinflammatori
aman
et
al
surfac
express
terawaki
et
al
limit
risk
tissu
damag
host
immun
system
mani
virus
evolv
differ
mechan
evad
host
ifn
respons
promot
replic
persist
randal
goodbourn
acut
fv
infect
type
ifn
respons
quit
weak
system
induct
type
ifn
detect
howev
low
level
express
ifna
mrna
could
found
spleen
cell
hour
post
fv
infect
gerlach
et
al
subtyp
express
higher
level
splenocyt
acut
fv
infect
compar
gerlach
et
al
furthermor
mrna
isg
detect
spleen
bone
marrow
fvinfect
mice
gerlach
et
al
gibbert
et
al
halemano
et
al
indic
local
express
subsequ
isg
respons
elicit
acut
fv
infect
previous
report
moloney
murin
leukemia
virusbas
retrovir
replic
vector
rrv
induc
measur
type
ifn
respons
furthermor
moloney
rrv
even
suppress
ifn
induct
viral
vector
indic
activ
counterregul
type
ifn
respons
lin
et
al
also
like
fv
infect
exact
molecular
mechan
poor
induct
type
ifn
fv
remain
elus
exogen
applic
subtyp
ifninduc
tlr
ligand
fv
infect
result
effici
viral
control
gerlach
et
al
gibbert
et
al
gibbert
et
al
halemano
et
al
experi
subtyp
shown
strongest
antifv
activ
vivo
gerlach
et
al
gibbert
et
al
harper
et
al
show
treatment
inhibit
acut
fv
replic
least
part
antivir
effector
molecul
harper
et
al
fig
protein
deoxycytidin
deaminas
gain
major
attent
discov
member
famili
counteract
protein
vif
sheehi
et
al
vif
bind
target
variou
member
degrad
via
ubiquitinproteasom
pathway
sheehi
gaddi
malim
stopak
et
al
human
member
ah
arjanodedra
et
al
contrast
mice
encod
one
gene
make
straightforward
deriv
knockout
ko
mice
okeoma
et
al
santiago
et
al
mous
doubledomain
deaminas
ntermin
half
evolutionarili
similar
domain
ctermin
half
bear
similar
refsland
harri
studi
fv
infect
reveal
ko
mice
higher
level
infecti
viru
compar
wt
mice
dpi
santiago
et
al
takeda
et
al
potent
vivo
inhibitori
activ
consist
across
multipl
murin
retrovirus
test
okeoma
et
al
low
et
al
jone
mehta
okeoma
importantli
molecular
counterpart
classic
resist
gene
recoveri
friend
viru
gene
santiago
et
al
takeda
et
al
santiago
et
al
mous
produc
infect
cell
get
incorpor
fmulv
particl
inhibit
replic
next
target
cell
brown
littman
antivir
mechan
deaminaseindepend
hypermut
revers
transcript
rare
detect
brown
littman
smith
et
al
barrett
et
al
boi
et
al
deaminasedead
retain
abil
restrict
mlv
vivo
stavrou
et
al
mechan
involv
steric
inhibit
revers
transcript
decreas
activ
fidel
revers
transcriptas
boi
et
al
interestingli
vivo
decreas
total
number
fv
particl
releas
dpi
despit
reduct
infecti
viremia
smith
et
al
substanti
releas
noninfecti
particl
act
antigen
help
prime
b
cell
respons
see
chapter
wherea
encod
vif
protein
counteract
antivir
effect
sheehi
et
al
fv
encod
glycogag
protein
evan
dresler
kabat
function
antagonist
kolokitha
et
al
glycogag
glycosyl
form
gag
origin
upstream
cug
initi
codon
essenti
mlv
replic
vivo
chun
fan
corbin
et
al
stavrou
et
al
glycogagdefici
casfr
moloney
mlv
sever
impair
replic
wt
mice
replic
similar
level
wt
viru
ko
mice
kolokitha
et
al
stavrou
et
al
like
vif
glycogag
directli
bind
vitro
unlik
vif
glycogag
appear
promot
degrad
kolokitha
et
al
contrast
glycogagdefici
mlv
unstabl
capsid
stimul
respons
strongli
wt
viru
suggest
glycogag
may
shield
mlv
dna
sens
cytoplasm
capsid
uncoat
stavrou
et
al
administr
fvldvinfect
mice
result
upregul
mani
known
restrict
factor
decreas
fv
replic
genet
inactiv
almost
complet
abrog
therapeut
effect
halemano
et
al
thu
act
major
effector
molecul
exogenouslyadminist
therapi
interestingli
ifnar
ko
background
still
reduc
earli
infecti
viremia
though
via
antibodymedi
mechan
barrett
et
al
furthermor
reduct
infecti
viremia
occur
presenc
absenc
ldv
thu
resist
mice
restrict
acut
fv
infect
requir
type
ifn
signal
surpris
sinc
murin
retrovirus
seem
suppress
endogen
ifn
product
minim
ifn
signal
acut
infect
lin
et
al
howev
defici
background
loss
ifnar
increas
acut
fv
viremia
barrett
et
al
find
suggest
low
amount
virusinduc
type
ifn
trigger
antivir
effector
contribut
inhibit
acut
fv
replic
vivo
one
import
type
ifnregul
factor
kd
protein
restrict
virion
releas
tetherin
counteract
vpu
protein
enhanc
virion
releas
neil
zang
bieniasz
van
damm
et
al
relev
tetherin
retrovir
infect
vivo
initi
confirm
studi
compar
moloney
mlv
context
treatment
murin
aid
infect
level
wt
versu
tetherin
ko
mice
liberator
bieniasz
fv
infect
model
genet
ablat
tetherin
mice
effect
viremia
dpi
timefram
adapt
immun
respons
alreadi
come
play
li
et
al
interestingli
dpi
tetherin
ko
mice
exhibit
weaker
nk
cell
cell
cell
respons
invers
correl
fv
infect
level
li
et
al
sinc
tetherin
effect
viremia
earli
time
point
dpi
contrast
li
et
al
propos
tetherin
may
act
immunomodul
cellmedi
immun
tetherin
inhibit
virion
releas
tether
virion
cellular
membran
two
end
ntermin
transmembran
domain
ctermin
gpianchor
perezcaballero
et
al
aggreg
virion
cell
surfac
quit
strike
neil
zang
bieniasz
vitro
tetherin
cell
infect
vpudefici
suscept
nk
cellmedi
antibodydepend
cellular
cytotox
aria
et
al
notabl
stapl
virion
particl
subsequ
lead
reuptak
virion
subsequ
degrad
endolysosom
pathway
neil
et
al
critic
step
mhc
ii
present
myeloid
dc
known
target
fv
infect
balkow
et
al
earli
dpi
tetherin
ko
myeloid
dc
exhibit
lower
activ
level
wt
dc
li
et
al
suggest
mechan
tetherin
influenc
cell
immun
may
link
antigen
present
addit
intern
tether
virion
probabl
lead
improv
viral
sens
endosom
sensor
myeloid
cell
result
upregul
cytokin
requir
facilit
nk
cell
activ
function
see
chapter
interestingli
special
mous
strain
nzwlacj
harbor
singl
nucleotid
polymorph
tetherin
start
site
result
truncat
protein
lack
ntermin
endocytosi
motif
barrett
et
al
nzw
tetherin
variant
express
higher
level
cell
surfac
due
defect
endocytosi
backcross
studi
mice
homozyg
nzw
tetherin
variant
exhibit
higher
viremia
weaker
nk
cell
respons
dp
fv
infect
compar
mice
express
tetherin
barrett
et
al
altogeth
result
suggest
endocytosiscompet
tetherin
promot
antigen
present
induc
reuptak
virion
dc
reuptak
virion
may
necessari
effici
mhc
present
unlik
free
protein
virion
capsid
protein
latticelik
structur
may
resist
proteas
degrad
mani
detail
endocytosiscompet
tetherin
promot
antigen
present
remain
unclear
note
human
also
express
endocytosisdefect
nzwlike
protein
due
translat
downstream
start
site
cocka
bate
detail
tetherin
variant
may
affect
cellmedi
immun
respons
remain
incomplet
restrict
factor
tetherin
potent
activ
mlv
identifi
vitro
interestingli
potent
inhibit
fv
vitro
factor
necessarili
translat
inhibit
vivo
ribonucleas
l
ko
mice
exhibit
similar
fv
viremia
level
wt
mice
behrendt
et
al
li
et
al
barrett
et
al
reason
differenti
activ
antiretrovir
protein
vitro
versu
vivo
remain
unclear
one
possibl
factor
may
evolv
potent
counteract
viru
famili
eg
ribonucleas
l
ko
mice
suscept
west
nile
viru
samuel
et
al
residu
activ
retrovirus
vitro
overexpress
artefact
altern
genet
environment
modifi
may
explain
multipl
restrict
factor
antiretrovir
activ
retain
throughout
mammalian
evolut
complement
system
compris
protein
play
import
role
innat
immun
upon
activ
classic
lectin
altern
pathway
proteolyt
cascad
initi
induc
lysi
invad
pathogen
infect
cell
holer
altern
deposit
complement
fragment
pathogen
surfac
enhanc
clearanc
phagocytosi
carrol
isenman
besid
role
innat
immun
complement
system
bridg
innat
adapt
immun
respons
involv
antibodi
matur
memori
bcell
format
modul
cell
respons
carrol
isenman
west
kolev
kemper
retrovirus
activ
complement
system
either
direct
abindepend
interact
first
compon
classic
pathway
ebenbichl
et
al
stoiber
et
al
addit
interact
retrovirus
mannosebind
lectin
initi
trigger
lectin
pathway
describ
thielen
tacnetdelorm
arlaud
ji
gewurz
spear
seroconvers
pathogenspecif
antibodi
trigger
complement
activ
initi
classic
complement
pathway
complement
protein
express
nearli
compart
host
invad
pathogen
confront
first
line
immun
defens
begin
infect
avoid
complementmedi
virolysi
retrovirus
adapt
two
main
strategi
similar
host
cell
virus
bind
fluidphas
regul
complement
activ
rca
factor
h
fh
surfac
avoid
destruct
activ
complement
defens
strategi
shown
human
simianderiv
retrovirus
freissmuth
dierich
stoiber
millernovak
et
al
also
fmulv
housiaux
hill
petersen
addit
incorpor
membraneanchor
rca
viral
membran
bud
process
shield
complement
attack
sever
retrovirus
found
primat
take
advantag
defens
mechan
montefiori
et
al
saifuddin
et
al
spear
et
al
stoiber
et
al
shown
mous
mammari
tumor
virus
mmtv
fmulv
murin
retrovirus
adapt
geneproteini
crri
rca
specif
rodent
hs
unpublish
observ
fh
crri
regul
complement
system
distinct
mechan
retrovir
virolysi
avoid
differ
activ
level
complement
cascad
laskowski
et
al
although
interf
sever
step
cascad
retrovirus
avoid
complement
activ
result
deposit
accumul
complement
fragment
viral
surfac
process
refer
opson
holer
similar
retrovirus
fv
turn
complementopson
advantag
deposit
viral
surfac
allow
interact
complementreceptor
cr
express
cell
erythrocyt
macrophag
monocyt
dc
b
cell
groenewegen
voogd
freedman
isitor
adogwa
banki
et
al
banki
et
al
bila
et
al
bind
fv
cr
may
help
viru
dissemin
host
result
complementmedi
enhanc
infect
hand
follicular
dc
fdc
trap
opson
retrovirus
germin
center
bind
bind
nativ
antigen
fdc
network
crucial
develop
b
cell
respons
germin
center
reaction
el
shikh
pitzali
retrovirus
bound
fdc
also
repres
import
viral
reservoir
banki
et
al
heester
et
al
hiv
infect
uptak
complementopson
virion
dc
express
effici
bypass
restrict
posch
et
al
murin
known
intrins
inhibitor
fv
vitro
behrendt
et
al
possibl
complement
may
involv
analog
manner
hiv
complementmedi
enhanc
infect
may
alway
advantag
viru
complementopson
hiv
shown
promot
mhc
present
dc
suggest
complement
direct
retrovirus
toward
mhc
recognit
tjomsland
et
al
inde
depend
opson
either
complement
protein
igg
hiv
associ
differ
mhc
compart
infect
dc
wilflingsed
et
al
posch
et
al
thu
accumul
viru
dc
increas
capac
present
antigen
virusspecif
cell
banki
et
al
studi
use
fv
mous
model
indic
enhanc
role
complement
dcmediat
cell
induct
also
occur
vivo
identifi
complement
natur
adjuv
dcinduc
expans
differenti
specif
cytotox
cell
fv
banki
et
al
addit
target
cr
dc
singlechain
antibodi
fragment
scfv
fuse
immunodomin
viral
antigen
use
induc
fvspecif
cell
respons
vivo
ejaz
et
al
similar
dc
polyclon
activ
b
cell
promot
infect
opson
fv
vitro
vivo
enhanc
infect
correl
increas
potenc
b
cell
activ
fvspecif
cell
bila
et
al
contrast
complement
iggopson
bind
capac
dc
activ
virusspecif
cell
posch
et
al
banki
et
al
thu
complement
two
side
coin
fv
infect
one
side
fv
take
advantag
opson
complement
protein
enhanc
viru
distribut
increas
infect
level
fig
side
complement
natur
adjuv
induct
fvspecif
cell
respons
crucial
control
acut
fv
infect
dittmer
race
hasenkrug
dittmer
et
al
chapter
natur
killer
nk
cell
innat
immun
cell
protect
tumor
mani
viru
infect
nk
cell
express
activ
inhibitori
receptor
facilit
kill
transform
virusinfect
cell
sever
antivir
effector
function
nk
cell
releas
cytotox
granul
cytokin
product
antibodi
depend
cellular
cytotox
describ
mani
studi
suggest
nk
cell
play
critic
role
retrovir
immun
retrovirus
evolv
strategi
escap
nk
cell
recognit
jost
altfeld
notabl
select
deplet
nk
cell
initi
phase
dpi
fv
infect
led
increas
viral
load
highlight
critic
role
nk
cell
earli
retroviru
control
vivo
littwitz
et
al
nk
cell
respons
fv
infect
heavili
influenc
dose
viru
inoculum
low
medium
dose
fv
sffu
nk
cell
partial
activ
limit
antivir
function
contrast
highdos
fv
infect
least
sffu
mice
result
higher
product
nk
cell
stimul
cytokin
macrophag
dc
littwitzsalomon
schimmer
dittmer
nk
cell
activ
highdos
infect
produc
earli
dpi
kill
fvtransform
tumor
cell
vitro
vivo
antiretrovir
antitumor
activ
report
link
nk
cell
activ
receptor
ogawa
et
al
addit
viru
inoculum
dose
type
ifn
viral
coinfect
may
also
drive
nk
cell
activ
murin
retrovirus
activ
suppress
type
ifn
express
lin
et
al
therapeut
administr
improv
nk
cell
function
viru
control
fvinfect
mice
gerlach
et
al
gibbert
et
al
nk
cell
preactiv
anoth
viru
infect
eg
mcmv
superinfect
fv
also
effici
control
francoi
et
al
antivir
impact
nk
cell
appear
limit
earli
fv
infect
select
deplet
nk
cell
dpi
affect
viral
load
littwitz
et
al
one
possibl
explan
fv
effici
control
cytotox
cell
time
point
joedick
et
al
interestingli
deplet
nk
cell
dpi
result
reduc
viral
load
significantli
improv
fvspecif
cell
respons
littwitz
et
al
data
suggest
nk
cell
inhibitori
role
transit
phase
acut
chronic
fv
infect
regulatori
effect
nk
cell
cell
respons
also
describ
lcmvinfect
mice
waggon
et
al
lang
et
al
underli
mechan
appear
involv
upregul
inhibitori
ligand
well
downregul
activ
ligand
cell
type
ifn
crous
et
al
xu
et
al
molecular
mechan
cell
suppress
nk
cell
fv
infect
remain
determin
initi
phase
fv
infect
dpi
subpopul
regulatori
cell
treg
limit
activ
antivir
function
nk
cell
littwitzsalomon
et
al
later
time
point
viru
inocul
treg
respond
fv
infect
activ
expans
hasenkrug
chougnet
dittmer
virusinduc
treg
suppress
nk
cell
even
effici
treg
mechan
action
involv
consumpt
avail
result
decreas
nk
cell
activ
littwitzsalomon
et
al
treg
suppress
could
overcom
fvinfect
mice
therapeut
administr
specif
direct
nk
cell
monoclon
antibodi
role
certain
nk
cellnk
celllik
subset
fv
infect
remain
activ
investig
persist
fv
infect
mice
could
induc
memorylik
nk
cell
littwitzsalomon
et
al
consist
infect
model
memorylik
nk
cell
show
improv
antivir
activ
upon
secondari
encount
fv
antigen
thu
featur
memori
cell
nkt
cell
also
activ
fv
infect
littwitzsalomon
schimmer
dittmer
infect
increas
nkt
cell
cytotox
potenti
fv
transform
tumor
cell
treatment
exogen
activ
led
increas
nkt
cell
number
improv
fv
control
studi
shed
insight
memorylik
nk
cell
nkt
cell
particip
retrovir
control
pathogenesi
conclud
nk
cell
serv
import
player
fv
immun
fig
exemplifi
tight
interplay
innat
adapt
arm
immun
system
regul
retrovir
infect
dc
import
link
innat
adapt
immun
system
take
antigen
becom
infect
virus
matur
enabl
effici
present
antigen
cell
fv
product
infect
dc
vitroand
vivo
balkow
et
al
fig
infect
level
increas
complement
opson
viru
banki
et
al
sens
fv
infect
effici
activ
dc
express
costimulatori
molecul
cell
interact
mechan
requir
ifn
product
gibbert
et
al
infect
dc
present
antigen
fvspecif
cell
prime
cell
respons
vitro
vivo
includ
function
matur
cytotox
cell
banki
et
al
li
et
al
fig
addit
dc
also
prime
fvspecif
helper
cell
li
et
al
howev
cell
shown
fvinfect
bone
marrowderiv
dc
acquir
tolerogen
phenotyp
balkow
et
al
shen
et
al
vitro
favor
induct
regulatori
cell
rather
effector
cell
balkow
et
al
taken
togeth
fvinfect
dc
play
import
role
fv
immun
link
innat
respons
specif
cell
activ
cell
heterogen
popul
cell
orchestr
immun
system
helper
regulatori
properti
moreov
also
mediat
direct
antifv
function
hasenkrug
brook
dittmer
iwashiro
et
al
nair
et
al
although
less
studi
counterpart
sever
cell
subset
induc
respons
fv
infect
iwashiro
et
al
antun
et
al
pike
et
al
nair
et
al
danelli
donnarumma
kassioti
mous
cell
haplotyp
target
numer
epitop
encod
fmlv
gag
pol
env
messer
lavend
hasenkrug
howev
studi
cell
respons
fv
focus
domin
epitop
fmulv
envelop
glycoprotein
iwashiro
et
al
cell
reactiv
fmulv
epitop
present
detect
use
varieti
techniqu
differ
sensit
includ
peptidespecif
cytokin
releas
assay
peptidemhc
ii
tetram
bind
howev
even
improv
tetram
reagent
captur
fraction
fmulvreact
cell
pool
thorborn
et
al
use
tcrtransgen
cell
bear
receptor
permit
accur
monitor
kinet
respons
fv
infect
independ
abil
secret
cytokin
bind
peptidemhc
tetram
may
compromis
treg
intrins
tcr
downregul
respect
nair
et
al
ploquin
eksmond
kassioti
prime
tcr
transgen
fmulvreact
cell
detect
day
fv
infect
peak
day
declin
thereaft
thorborn
et
al
merkenschlag
et
al
cell
kinet
delay
mice
increas
suscept
fv
infect
nair
et
al
peak
cell
respons
fv
infect
appear
preced
peak
cell
respons
fmulvspecif
cell
critic
control
fv
infect
marqu
et
al
pike
et
al
earli
studi
highlight
import
role
cell
provid
help
antibodi
respons
super
et
al
hasenkrug
inde
fmulvreact
cell
demonstr
robust
follicular
helper
tfh
differenti
much
stronger
cell
respond
viral
infect
ploquin
eksmond
kassioti
danelli
donnarumma
kassioti
fmulvreact
cell
also
promot
cellular
immun
although
dispens
prime
fmulvreact
cytotox
cell
cell
help
promot
surviv
cytotox
effector
cell
nair
et
al
moreov
fmulvreact
cell
exhibit
direct
antivir
activ
independ
arm
adapt
immun
hasenkrug
brook
dittmer
iwashiro
et
al
cell
long
shown
mediat
reject
fvinduc
transplant
tumor
includ
lack
mhc
ii
express
greenberg
cheever
fefer
greenberg
kern
cheever
antitumor
effect
larg
attribut
product
cell
although
studi
fv
infect
highlight
protect
effect
virusspecif
cell
independ
host
pike
et
al
fvspecif
cell
also
shown
acquir
cytotox
activ
mhc
iiexpress
target
chronic
fv
infect
malyshkina
et
al
cytotox
activ
fasldepend
wherea
granzymedepend
cytotox
develop
respons
fmulv
immun
deliv
heterolog
viral
vector
donnarumma
et
al
appear
suppress
treg
natur
fv
infect
manzk
et
al
malyshkina
et
al
inde
treg
shown
strongli
activ
prolif
fv
infect
suppress
function
subset
fvspecif
effector
cell
acut
chronic
phase
infect
nair
et
al
manzk
et
al
moor
et
al
recent
studi
defin
tcr
avid
major
determin
cell
respons
protect
fv
infect
explor
role
select
expans
mainten
distinct
cell
clonotyp
thorborn
young
kassioti
merkenschlag
kassioti
studi
util
fvspecif
chaintransgen
mice
mice
semipolyclon
tcr
repertoir
increas
frequenc
cell
clonotyp
antun
et
al
ploquin
eksmond
kassioti
importantli
function
avid
tcr
system
determin
particular
chain
use
tcr
famili
chain
encod
gene
segment
famili
chain
encod
gene
segment
creat
clonotyp
higher
lower
function
avid
respect
antun
et
al
ploquin
eksmond
kassioti
surprisingli
despit
enorm
potenti
recombinatori
somat
tcr
repertoir
format
abil
gene
segment
gener
highavid
tcr
least
part
germlin
encod
young
et
al
find
underscor
import
polymorph
germlin
tcr
gene
segment
attribut
recreat
random
somat
recombin
select
format
highavid
tcr
requir
presenc
appropri
allel
germlin
young
et
al
howev
germlin
allel
alon
suffici
enrich
repertoir
highavid
tcr
tcr
succeed
thymic
select
excess
selfreact
disadvantag
particularli
problemat
tcr
reactiv
retrovir
antigen
given
mammalian
genom
compris
numer
endogen
retrovirus
potenti
express
selfpeptid
retrovir
origin
mediat
posit
neg
thymic
select
inde
thymic
select
cell
heavili
shape
singlecopi
endogen
ecotrop
mlv
genom
mice
bear
high
similar
fmulv
young
et
al
howev
tcr
crossreact
epitop
variant
encod
fmulv
invers
proport
avid
either
variant
tcr
highest
avid
fmulv
env
least
crossreact
env
young
et
al
studi
provid
proof
principl
neg
select
selfpeptid
fact
enhanc
instead
diminish
represent
clonotyp
high
avid
remov
compet
clonotyp
albeit
expens
crossreact
longterm
increas
frequenc
antigenreact
lymphocyt
clonal
expans
select
hallmark
immunolog
memori
aim
vaccin
although
gener
consensu
cell
clonal
select
immun
respons
basi
tcr
signal
strength
respons
antigen
underli
factor
respons
differ
tcr
sensit
antigen
stimul
still
matter
debat
merkenschlag
kassioti
tcr
bind
kinet
antigen
peptidemhc
pmhc
complex
tradit
consid
domin
factor
determin
strength
cell
activ
howev
studi
fv
model
merkenschlag
et
al
well
independ
model
persaud
et
al
emphas
import
tcr
selfreact
set
tcr
respons
antigen
experi
tcrtransgen
mice
correl
differ
function
avid
biolog
respons
selfreact
rather
affin
antigen
merkenschlag
et
al
surprisingli
uncov
b
cell
present
antigen
power
cellextrins
factor
revers
tcr
sensitivitybas
hierarchi
antigenmedi
clonal
select
therebi
preserv
divers
antigenselect
tcr
repertoir
merkenschlag
et
al
contrast
treg
repres
anoth
cellextrins
factor
shown
restrict
tcr
repertoir
cell
fontain
et
al
therefor
clonotyp
evolut
respons
fv
shape
rel
balanc
kinet
b
cell
treg
activ
tcr
interact
distinct
antigenpres
cell
apc
subset
well
regul
treg
determin
clonotyp
composit
cell
also
function
differenti
addit
power
effect
cellextrins
factor
cytokin
effector
cell
differenti
also
influenc
tcr
avid
cellintrins
manner
linterman
vinuesa
lo
allen
thorborn
young
kassioti
integr
multipl
cellextrins
cellintrins
variabl
affect
cell
differenti
creat
necessari
divers
function
cell
respons
tailor
natur
antigen
contrast
typic
balanc
respons
viral
infect
cell
respons
fv
infect
recent
shown
heavili
skew
toward
tfh
differenti
danelli
donnarumma
kassioti
bias
tfh
differenti
respons
fv
infect
clearli
promot
tcr
signal
strength
measur
report
tcr
signal
experiment
manipul
alter
epitop
affect
tcr
clonotyp
avid
danelli
donnarumma
kassioti
notabl
differ
tcr
signal
strength
experienc
tfh
cell
due
differ
avid
respect
tcr
repertoir
rather
consequ
differenti
interact
distinct
subset
apc
danelli
donnarumma
kassioti
central
role
apc
also
underli
induct
distinct
ratio
tfh
cytotox
cell
differ
vaccin
vector
immun
regimen
fv
model
donnarumma
et
al
shen
et
al
although
cell
observ
differenti
treg
natur
cours
fv
infect
antun
et
al
myer
et
al
thymicallyderiv
treg
highli
polyclon
tcr
specif
strongli
activ
expand
fv
infect
hasenkrug
chougnet
dittmer
inde
studi
model
first
implic
treg
regul
adapt
immun
infect
iwashiro
et
al
expans
involv
treg
react
fv
antigen
rather
selfantigen
fuel
least
two
separ
mechan
first
natur
thymusderiv
treg
constitut
express
high
affin
receptor
polyclon
activ
secret
fmulvreact
cell
gitr
ligand
express
activ
b
cell
myer
et
al
moor
et
al
second
thymusderiv
treg
bear
famili
chain
specif
react
retrovir
superantigen
encod
endogen
mous
mammari
tumor
viru
myer
et
al
joedick
et
al
mode
treg
expans
account
one
everi
treg
modul
membranebound
signal
deliv
fmulvreact
cell
myer
et
al
joedick
et
al
detail
treg
respons
fv
infect
recent
review
hasenkrug
chougnet
dittmer
togeth
studi
highlight
complex
cellular
interact
respons
shape
common
well
uniqu
attribut
fvspecif
effector
cell
respons
fig
cell
play
central
role
protect
acut
infect
virus
cell
respons
extens
studi
mice
infect
fv
model
help
us
understand
function
cell
kinet
respons
mechan
immun
system
control
respons
earli
map
fv
resist
gene
show
mhc
gene
essenti
high
recoveri
phenotyp
mice
suggest
class
irestrict
cell
respons
import
recoveri
chesebro
miyazawa
britt
experi
use
cell
deplet
confirm
cell
inde
critic
recoveri
even
highli
resist
mice
robertson
et
al
hasenkrug
robertson
et
al
predomin
expans
cell
fv
infect
found
organ
highest
viral
replic
spleen
bone
marrow
zelinskyy
et
al
larg
proport
fvactiv
cell
recogn
immunodomin
fv
gagl
epitop
dbgagl
chen
et
al
studi
immunodomin
respons
facilit
develop
tetram
stain
dbgaglspecif
cell
scheper
et
al
transgen
cell
bear
tcr
specif
dbgagl
epitop
ohlen
et
al
stain
tcr
activ
marker
cell
fv
infect
indic
also
cell
respond
epitop
dbgagl
fvinfect
resist
mice
activ
virusspecif
cell
detect
earli
day
post
infect
robertson
et
al
zelinskyy
et
al
peak
expans
fvspecif
cell
occur
within
next
day
week
depend
mous
strain
whether
coinfect
virus
robertson
et
al
clear
evid
activ
fvspecif
cell
driven
dc
banki
et
al
virusinfect
b
cell
also
shown
import
antigenpres
cell
cell
respons
bila
et
al
moor
et
al
particularli
viru
opson
complement
bila
et
al
mani
viral
infect
prime
cell
respons
seem
cell
independ
acut
fv
infect
nair
et
al
mice
deplet
cell
acut
infect
unabl
effici
control
viru
replic
develop
sever
splenomegali
even
leukemia
robertson
et
al
hasenkrug
robertson
et
al
joedick
et
al
antivir
activ
cell
clearli
associ
abil
produc
cytotox
molecul
activ
fvspecif
cell
produc
granzym
b
well
perforin
zelinskyy
et
al
execut
effici
kill
gaglpres
target
cell
vivo
zelinskyy
et
al
interestingli
express
one
three
mention
cytotox
molecul
seem
suffici
mediat
antifv
cytotox
mice
lack
three
molecul
rapidli
succumb
infect
zelinskyy
et
al
thu
exocytosi
pathway
central
mechan
antivir
activ
cell
howev
mice
infect
low
dose
fv
weakli
replic
fmulv
helper
viru
cell
switch
exocytosi
pathway
rather
control
low
level
infect
use
fa
ligandfa
pathway
target
cell
kill
zelinskyy
et
al
zelinskyy
werner
dittmer
addit
direct
kill
fvactiv
cell
also
produc
proinflammatori
cytokin
especi
zelinskyy
et
al
also
experiment
evid
product
well
directli
contribut
fv
control
iwashiro
et
al
stromn
et
al
myer
et
al
late
phase
acut
fv
infect
week
pi
function
activ
cell
dramat
chang
cell
reduc
number
contract
phase
start
develop
sever
dysfunct
gradual
lose
abil
produc
granzym
perforin
subsequ
express
zelinskyy
et
al
zelinskyy
et
al
consequ
fvspecif
cell
appear
function
exhaust
ineffici
kill
peptidelabel
target
vivo
zelinskyy
et
al
howev
small
subset
function
cell
preserv
even
chronic
infect
uniqu
express
cell
surfac
protein
myer
et
al
cell
exhaust
contribut
subsequ
develop
fv
chronic
dietz
et
al
similar
describ
chronic
lcmv
infect
barber
et
al
surprisingli
experiment
deplet
exhaust
cell
chronic
infect
observ
effect
chronic
fv
load
hasenkrug
brook
dittmer
studi
use
fv
model
defin
sever
cell
popul
molecul
contribut
develop
cell
dysfunct
subsequ
viral
chronic
similar
discov
lcmv
model
barber
et
al
inhibitori
receptor
express
effector
cell
play
import
role
function
exhaust
sever
inhibitori
receptor
upregul
cell
chronic
fv
infect
zelinskyy
et
al
dietz
et
al
domin
suppress
activ
seem
mediat
program
cell
death
protein
term
inhibitori
receptor
chronic
infect
express
use
surrog
marker
exhaust
cell
block
signal
receptor
antibodi
reactiv
exhaust
cell
barber
et
al
dietz
et
al
block
axi
result
expans
function
cell
express
myer
et
al
increas
express
coinhibitori
molecul
like
prevent
immunopathogen
effect
overstimul
cell
respons
upregul
initi
acut
fv
infect
zelinskyy
et
al
result
indic
simpl
express
coinhibitori
costimulatori
molecul
dictat
function
effector
cell
whether
balanc
signal
molecul
inhibitori
stimulatori
inflammatori
milieu
present
acut
infect
balanc
tilt
toward
high
function
infect
clear
inflamm
declin
balanc
tilt
toward
inhibit
protect
immunopatholog
fv
infect
develop
subpopul
virusinfect
cell
b
cell
granulocyt
cell
start
express
high
level
ligand
akhmetzyanova
et
al
enhanc
express
protect
cell
cytolyt
cell
kill
seed
reservoir
chronic
infect
cell
time
frequent
contact
virusspecif
cell
protect
target
result
function
impair
effector
cell
due
interact
akhmetzyanova
et
al
recent
shown
pathway
involv
cell
exhaust
also
influenc
prolifer
apoptosi
cell
acut
fv
infect
david
et
al
addit
mechan
inhibit
also
specif
cell
type
contribut
cell
dysfunct
chronic
fv
infect
import
role
treg
viral
chronic
first
describ
fv
model
iwashiro
et
al
dittmer
et
al
treg
becom
activ
expand
late
phase
acut
fv
infect
zelinskyy
et
al
subsequ
suppress
prolifer
function
includ
cytotox
cytokin
product
effector
cell
zelinskyy
et
al
zelinskyy
et
al
surprisingli
experiment
deplet
treg
acut
fv
infect
augment
cytotox
cell
respons
improv
viru
control
zelinskyy
et
al
moor
et
al
treg
ablat
chronic
infect
reactiv
exhaust
cell
includ
induct
cytotox
cytokin
product
also
result
reduc
viral
load
dietz
et
al
interestingli
activ
expans
treg
partli
driven
activ
effector
cell
via
express
membranebound
bind
tnf
receptor
thymusderiv
treg
myer
et
al
joedick
et
al
far
exact
molecular
mechan
treg
exert
immunosuppress
influenc
cell
remain
unknown
hasenkrug
chougnet
dittmer
mechan
cell
exhaust
describ
express
treg
expans
independ
event
block
pathway
simultan
synergist
effect
cell
mediat
viru
control
dietz
et
al
recent
discov
third
mechan
cell
suppress
fv
model
mediat
myeloid
deriv
suppressor
cell
mdsc
drabczykpluta
et
al
suppress
b
cell
respons
mdsc
describ
anoth
mous
retroviru
model
review
rastad
green
found
granulocyt
mdsc
restrict
function
activ
fvspecif
cell
suppress
involv
arginas
atp
dephosphoryl
enzym
addit
nk
cell
also
abl
suppress
cell
respons
later
phase
fv
infect
molecular
mechan
remain
determin
littwitz
et
al
thu
cell
respons
strongli
modulatedrestrict
fv
infect
fig
tight
control
necessari
overact
cell
danger
host
viru
infect
edg
sword
though
suppress
cell
respons
allow
chronic
infect
develop
evolutionari
point
view
chronic
infect
often
produc
less
sever
select
pressur
immunopatholog
case
fv
chronic
infect
mice
normal
reproduct
rate
anim
develop
leukemia
late
life
hasenkrug
brook
dittmer
shown
fvinfect
mice
mount
antibodi
respons
fv
virion
fv
leukemia
cell
old
boys
lilli
import
antibodi
demonstr
studi
show
passiv
antibodi
transfer
fvspecif
antibodi
could
protect
fvinduc
leukemia
wheelock
et
al
howev
passiv
antibodi
transfer
protect
mous
strain
also
abl
mount
essenti
cellmedi
immun
respons
thu
deplet
either
cell
ablat
antibodymedi
protect
hasenkrug
brook
chesebro
found
abil
differ
mous
strain
mount
virusneutr
antibodi
respons
control
singl
autosom
nonmhc
gene
gene
term
recoveri
friend
viru
gene
shown
essenti
control
viremia
prevent
leukemia
chesebro
wehrli
chesebro
et
al
britt
chesebro
studi
reveal
mice
deplet
tcell
vivo
show
undetect
fvneutral
antibodi
respons
high
viremia
reduc
surviv
time
thu
thelper
cell
requir
fvneutral
antibodi
respons
includ
igm
respons
super
et
al
helper
cell
known
follicular
helper
tfh
cell
kassioti
ogarra
fv
infect
induc
strongli
bias
differenti
cell
tfh
cell
danelli
donnarumma
kassioti
microsatellit
map
experi
undertaken
effort
determin
ident
gene
show
map
centimorgan
region
chromosom
hasenkrug
et
al
studi
narrow
locat
centimorgan
region
super
et
al
kanari
et
al
identifi
region
gene
rich
though
contain
least
gene
unlink
mhc
immunoglobulin
loci
cell
receptor
loci
one
gene
particular
interest
mous
see
chapter
exhibit
strike
function
polymorph
correl
phenotyp
inbr
mous
strain
resist
mice
express
truncat
protein
lack
exon
resist
retrovir
proteas
abudu
et
al
li
et
al
suscept
mice
balbc
abi
awysn
express
fulllength
lower
mrna
level
resist
mice
takeda
et
al
okeoma
petersen
ross
sanvil
et
al
santiago
et
al
halemano
et
al
target
genet
inactiv
combin
genet
backcross
studi
demonstr
inde
control
neutral
antibodi
respons
fv
infect
encod
phenotyp
santiago
et
al
mous
promot
germin
center
b
cell
develop
acut
fv
infect
santiago
et
al
stage
b
cell
develop
direct
indirect
model
may
explain
influenc
nab
respons
indirect
effect
link
uniqu
mechan
restrict
acut
fv
replic
shown
although
decreas
titer
infecti
viru
acut
fv
infect
plasma
viral
rna
load
maintain
smith
et
al
find
indic
restrict
promot
neutral
antibodi
respons
maintain
high
concentr
virion
nativ
b
cell
epitop
context
low
virion
infect
direct
effect
antibodi
respons
somat
hypermut
somat
hypermut
integr
process
affin
matur
antibodi
import
develop
highli
avid
antibodi
necessari
protect
viral
infect
somat
hypermut
occur
via
enzymat
activ
activationinduc
deaminas
aid
enzym
evolutionarili
relat
howev
contrast
aid
prefer
mutat
deoxycytidin
preced
purin
member
includ
preferenti
mutat
deoxycytidin
preced
pyrimidin
chelico
pham
goodman
studi
show
complement
aid
drive
immunoglobulin
gene
somat
hypermut
retroviru
infect
reveal
novel
mechan
promot
neutral
antibodi
respons
essenti
recoveri
retrovir
infect
halemano
et
al
apobecmedi
somat
hypermut
may
also
relev
vaccin
develop
broadlyneutr
antibodi
achiev
crossclad
neutral
heavili
mutat
highli
mutat
immunoglobulin
gene
like
improb
protein
structur
promot
neutral
breadth
wieh
et
al
main
target
fvspecif
neutral
antibodi
fmulv
env
protein
isol
fvspecif
neutral
monoclon
antibodi
suggest
multipl
mechan
inhibit
inhibit
expans
virusproduc
cell
promot
nk
cellmedi
adcc
complementdepend
neutral
vitro
review
halemano
et
al
sequenc
comparison
monoclon
antibodi
versu
mice
suggest
protect
neutral
antibodi
associ
subclass
specif
vh
gene
famili
increas
bind
affin
virion
higher
somat
mutat
halemano
et
al
passiv
transfer
studi
neutral
activ
antibodi
shown
depend
activ
receptor
complement
halemano
et
al
abil
b
cell
becom
activ
respond
infect
strongli
modul
treg
provid
level
homeostat
suppress
b
cell
b
cell
modul
reduc
potenti
gener
autoimmun
antibodi
ensur
specif
respons
associ
danger
signal
pathogen
elicit
antibodi
product
mice
infect
fv
induc
robust
expans
treg
deplet
treg
led
elev
activ
prolifer
class
switch
b
cell
moor
messer
hasenkrug
addit
treg
deplet
enhanc
kinet
product
level
virusspecif
virusneutr
antibodi
also
reduc
fv
viremia
thu
similar
cell
respons
specif
b
cell
respons
viral
infect
must
overcom
threshold
level
tregmedi
suppress
antibodi
respons
mount
moor
messer
hasenkrug
fig
antibodi
product
fv
infect
obvious
import
function
b
cell
studi
also
indic
antigen
present
b
cell
import
stimul
cytotox
lymphocyt
respons
exampl
complement
opson
fv
enhanc
infect
b
cell
vitro
increas
abil
activ
fvspecif
cell
bila
et
al
recent
studi
shown
fv
infect
dc
reduc
apc
capac
balkow
et
al
shen
et
al
infect
b
cell
produc
stimulatori
effect
evidenc
increas
express
costimulatori
molecul
requir
apc
function
furthermor
fvinfect
b
cell
significantli
better
apc
function
uninfect
b
cell
mous
measur
capac
prime
cell
activ
prolifer
vitro
moor
et
al
discuss
chapter
cell
antigen
present
b
cell
also
import
gener
high
avid
fvspecif
cell
ploquin
eksmond
kassioti
antigen
present
function
b
cell
fall
tregmedi
suppress
similar
manner
describ
antibodi
product
b
cell
thu
deplet
treg
even
mice
strongli
upregul
costimulatori
molecul
express
b
cell
enhanc
apc
function
cell
prime
moor
et
al
discuss
earlier
fv
infect
induc
activ
prolifer
treg
immunosuppress
activ
cell
b
cell
unexpectedli
fvinduc
treg
respons
depend
b
cell
provid
essenti
signal
treg
expans
fv
infect
fig
treg
respons
greatli
diminish
b
celldefici
mice
restor
adopt
transfer
b
cell
time
infect
feebl
treg
respons
b
celldefici
mice
associ
enhanc
virusspecif
cell
respons
acceler
viru
control
first
week
infect
vitro
experi
demonstr
b
cell
promot
treg
activ
prolifer
glucocorticoidinduc
receptor
superfamili
member
gitr
liganddepend
mechan
thu
b
cell
play
paradox
oppos
role
fv
infect
provid
prolif
signal
immunsuppress
treg
slow
earli
viru
control
suppress
cell
b
cell
respons
also
produc
virusspecif
antibodi
essenti
longterm
viru
control
moor
et
al
anoth
interest
interact
lymphocyt
subset
respond
fv
infect
expans
tfh
cell
necessari
promot
b
cell
respons
enhanc
presenc
treg
treg
shown
act
sink
fv
infect
littwitzsalomon
et
al
low
concentr
promot
tfh
differenti
germin
center
format
ballesterostato
et
al
danelli
donnarumma
kassioti
thu
one
hand
fvinduc
expans
treg
enhanc
tfh
differenti
therebi
promot
antibodi
respons
hand
b
cell
respons
suppress
fvinduc
treg
discuss
complex
dual
natur
intercellular
interact
reveal
delic
balanc
system
evolv
react
overreact
pathogen
challeng
last
decad
fv
model
extens
use
design
test
novel
concept
immunotherapi
infecti
diseas
fv
model
provid
opportun
studi
immunotherapeut
enhanc
viral
immun
acut
infect
also
establish
chronic
viral
infect
tabl
two
phase
infect
present
distinct
immunolog
environ
uniqu
requir
success
immunotherapi
elucid
variou
molecular
cellular
effector
elicit
phase
fv
infect
inform
target
therapi
improv
viru
control
variou
modal
acut
phase
one
first
antivir
effector
type
ifn
sometim
use
treat
viral
infect
clinic
sinc
fv
induc
weak
endogen
type
ifn
respons
upon
infect
exogen
thought
interest
approach
immunotherapi
also
interest
model
test
hypothesi
differ
subtyp
would
vari
efficaci
viru
control
inde
certain
subtyp
abl
restrict
acut
fv
replic
vivo
gerlach
et
al
gibbert
et
al
mechan
action
like
direct
induct
antivir
restrict
factor
see
chapter
also
immunomodulatori
properti
mous
abl
augment
earli
fvspecif
cell
respons
wherea
mainli
activ
nk
cell
respons
gerlach
et
al
gibbert
et
al
similar
find
made
ifn
respons
induc
tlr
ligand
rather
inject
olbrich
et
al
ligand
gibbert
et
al
mediat
ifndepend
direct
antivir
activ
well
stimulatori
effect
virusspecif
cell
besid
subtyp
cytokin
enhanc
nk
cell
respons
shown
restrict
initi
fv
replic
includ
specif
target
nk
cell
littwitzsalomon
et
al
littwitzsalomon
dittmer
sutter
littwitzsalomon
schimmer
dittmer
contrast
effect
exclus
reli
activ
nk
cell
immunolog
mechan
involv
therapeut
effect
earli
fv
infect
could
also
achiev
stimul
nkt
cell
exogen
activ
littwitzsalomon
schimmer
dittmer
antibodymedi
blockad
glucocorticoidinduc
tumor
necrosi
factor
receptor
treg
acut
fv
infect
produc
faster
respons
reduc
viru
load
patholog
interestingli
immunotherapeut
also
improv
longterm
cell
function
et
al
although
gener
consid
potent
antivir
cytokin
experi
fvinfect
mice
coinfect
ldv
demonstr
ldvinduc
actual
detriment
control
acut
fv
deliveri
antibodi
acut
fv
result
significantli
reduc
viru
level
better
cell
respons
absenc
duley
et
al
neg
effect
cell
indirect
involv
receptor
cell
anoth
effect
promot
fv
infect
b
cell
interestingli
detriment
effect
earli
fvspecif
immun
respons
replac
week
postinfect
requir
maintain
viru
control
especi
term
develop
high
titer
classswitch
antibodi
respons
stromn
et
al
experi
illustr
time
immunomodulatori
therapeut
respect
diseas
cours
absolut
critic
efficaci
virusspecif
cell
respons
critic
earli
fv
control
first
appear
around
week
post
fv
infect
sinc
cell
control
suppress
treg
well
mdsc
surpris
deplet
suppressor
enhanc
cell
respons
reduc
level
acut
fv
infect
review
hasenkrug
chougnet
dittmer
experi
show
number
differ
target
molecul
cell
type
immun
system
manipul
immunotherapi
influenc
outcom
acut
retrovir
infect
although
mice
resist
genet
background
abl
bring
acut
fv
infect
control
chronic
lowlevel
infect
ensu
combin
chronic
antigen
stimul
suppress
treg
mdsc
establish
immunosuppress
milieu
present
complic
therapeut
situat
chronic
phase
infect
cytotox
cytokinemedi
antivir
activ
effector
cell
larg
incapacit
zelinskyy
et
al
zelinskyy
et
al
although
recent
result
indic
small
subset
cell
express
remain
function
myer
et
al
thu
immunotherapi
chronic
viral
infect
mainli
aim
restor
function
virusspecif
cell
expand
function
subset
concept
also
relev
chronic
human
infect
virus
like
hiv
hbv
treatment
cancer
shown
block
inhibitori
signal
treg
deplet
dietz
et
al
antibodi
blockad
dietz
et
al
mdsc
deplet
drabczykpluta
et
al
result
reactiv
cell
signific
reduct
chronic
fv
set
point
combin
therapi
target
treg
time
improv
checkpoint
immunotherapi
dietz
et
al
addit
enhanc
control
chronic
viru
modul
suppress
coinhibitori
molecul
also
shown
immunostimulatori
therapi
could
use
agonist
antibodi
target
costimulatori
molecul
reactiv
fvspecif
effector
cell
malyshkina
et
al
malyshkina
et
al
made
refractori
treg
suppress
robertson
et
al
could
even
reprogram
treg
effector
cell
kill
fvtransform
tumor
cell
akhmetzyanova
et
al
nanoparticl
vaccin
deliv
fv
antigen
molecul
tlr
stimul
abl
induc
potent
cell
respons
restrict
chronic
fv
infect
knuschk
et
al
success
therapeut
vaccin
depend
type
ifn
induct
knuschk
et
al
could
improv
treg
deplet
knuschk
et
al
taken
togeth
result
sever
decad
research
fv
immun
provid
detail
pictur
differ
phase
retrovir
immun
acut
infect
chronic
fig
unexpect
interact
intrins
innat
adapt
immun
reveal
acut
infect
fig
exampl
intrins
restrict
factor
apobec
tetherin
shown
influenc
nk
cell
b
cell
cell
respons
complement
opson
viru
shown
strongli
influenc
fvspecif
cell
respons
find
import
develop
immunotherapi
vaccin
area
research
also
inform
novel
discoveri
immun
regul
chronic
fv
infect
host
respons
chronic
infect
involv
complex
state
immun
effector
function
control
viru
counterregulatori
mechan
avert
immmunopatholog
mechan
tregmedi
suppress
first
describ
fv
model
discoveri
let
therapeut
manipul
tip
immunolog
balanc
toward
immun
mechansim
significantli
reduc
chronic
infect
howev
even
success
immunotherapi
experi
chronic
fvinfect
mice
abl
achiev
viral
clearenc
goal
also
still
unmet
hiv
research
thu
futur
studi
concentr
novel
combin
therapi
target
differ
mechan
viral
persist
immun
evas
provid
proof
concept
retrovir
cure
function
cure
complex
virushost
interact
acut
fv
infect
transit
chronic
infect
proven
highli
relev
persist
infect
human
abil
studi
treat
phase
infect
make
fv
model
attract
one
develop
test
therapeut
effect
viru
intric
interact
variou
compon
immun
system
